SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
40 hedge funds and large institutions have $60M invested in scPharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 15 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
40
Holders Change
+2
Holders Change %
+5.26%
% of All Funds
0.69%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
9
Reduced
15
Closed
2
Calls
$131K
Puts
$82K
Net Calls
+$49K
Net Calls Change
+$49K
Top Buyers
| 1 |
JGC
J. Goldman & Co
New York
|
+$330K |
| 2 |
Group One Trading
Chicago,
Illinois
|
+$167K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$148K |
| 4 |
RWM
Ritholtz Wealth Management
New York
|
+$98K |
| 5 |
Envestnet Asset Management
Chicago,
Illinois
|
+$92K |
Top Sellers
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$3.84M |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
-$2.64M |
| 3 |
5VM
5AM Venture Management
San Francisco,
California
|
-$1.48M |
| 4 |
AC
Armistice Capital
New York
|
-$1.36M |
| 5 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$961K |
